ilShinbiobase Co. Ltd (068330) — Capital Reinvestment Ratio
ilShinbiobase Co. Ltd (068330) has a Capital Reinvestment Ratio of 0.01x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩3.46 Billion) in capital expenditures (₩38.55 Million). For the full cash flow conversion analysis, see ilShinbiobase Co. Ltd (068330) cash conversion ratio.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ilShinbiobase Co. Ltd Capital Reinvestment Ratio (2014–2025)
This chart tracks ilShinbiobase Co. Ltd's Capital Reinvestment Ratio across 12 annual periods. Check 068330 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Annual Capital Reinvestment Ratio for ilShinbiobase Co. Ltd (2014–2025)
Year-by-year Capital Reinvestment Ratio for ilShinbiobase Co. Ltd from 2014 to 2025. See how liquid is ilShinbiobase Co. Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | ₩5.27 Billion | ₩20.64 Million | ▼ -69.8% |
| 2024 | 0.01x | ₩4.12 Billion | ₩53.53 Million | ▼ -70.6% |
| 2023 | 0.04x | ₩5.92 Billion | ₩262.17 Million | ▼ -77.6% |
| 2022 | 0.20x | ₩2.65 Billion | ₩522.59 Million | ▲ +857.4% |
| 2021 | 0.02x | ₩6.74 Billion | ₩139.12 Million | ▼ -89.6% |
| 2020 | 0.20x | ₩4.50 Billion | ₩892.64 Million | ▲ +348.1% |
| 2019 | 0.04x | ₩5.55 Billion | ₩245.41 Million | ▼ -44.1% |
| 2018 | 0.08x | ₩4.88 Billion | ₩385.81 Million | ▼ -59.0% |
| 2017 | 0.19x | ₩2.11 Billion | ₩407.59 Million | ▲ +113.2% |
| 2016 | 0.09x | ₩3.01 Billion | ₩271.94 Million | ▼ -75.4% |
| 2015 | 0.37x | ₩270.22 Million | ₩99.39 Million | ▲ +1105.2% |
| 2014 | 0.03x | ₩3.33 Billion | ₩101.50 Million | — |